Vaccines were developed for 16 human-infecting viruses
Therapeutic drugs were developed for only 9 human-infecting viruses
Life-threatening viruses including HBV, Zika virus and measles virus have no drugs available to treat
We develop the MoSTT-ViP (Molecular Screening Technology Targeting a Virus Protein) technology, a high-throughput screening technology that can screen out molecules inhibiting the function of a viral protein.
Like COVID-19, humans continue to be exposed to life-threatening viruses, for many of which no drug is currently available to treat.
We use our MoSTT-ViP technology to develop therapeutic drugs for these no drug-available, life-threatening viruses such as HBV and Zika virus.
MoSTT-ViP screening system
MoSTT-ViP screening system : 2 module-integrated system
Viral Protein module (ViP-module)
Signal Producing (SP-module)
MoSTT-ViP systems can be quickly constructed tailored for a specific viral protein by exchanging ViP-module at a low cost & in short period of time
